Promoting smoking cessation in Bangladeshi and Pakistani male adults: design of a pilot cluster randomised controlled trial of trained community smoking cessation workers by Begh, Rachna A et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
Trials
Open Access Study protocol
Promoting smoking cessation in Bangladeshi and Pakistani male 
adults: design of a pilot cluster randomised controlled trial of 
trained community smoking cessation workers
Rachna A Begh1, Paul Aveyard1, Penney Upton2, Raj S Bhopal3, 
Martin White4, Amanda Amos5, Robin J Prescott3, Raman Bedi6, 
Pelham Barton7, Monica Fletcher8, Paramjit Gill1, Qaim Zaidi9 and 
Aziz Sheikh*10,11
Address: 1UK Centre for Tobacco Control Studies, Primary Care Clinical Sciences, University of Birmingham, Birmingham, B15 2TT, UK, 
2Psychological Sciences, Institute of Health and Society, University of Worcester, Worcester, WR2 6AJ,UK, 3Public Health Sciences Section, Centre 
for Population Health Sciences, The University of Edinburgh, Medical School, Teviot Place, Edinburgh, EH8 9AG, UK, 4Centre for Translational 
Research in Public Health, Institute of Health & Society, Newcastle University, NE2 4HH, UK, 5UK Centre for Tobacco Control Studies, Public 
Health Sciences Section, Centre for Population Health Sciences, The University of Edinburgh, Medical School, Teviot Place, Edinburgh, EH8 9AG, 
UK, 6International Centre for Child Oral Health, King's College London, 26-29 Drury Lane, London, WC2B 5RL, UK, 7Health Economics, 
University of Birmingham, Birmingham, B15 2TT, UK, 8Education for Health, 10 Church Street, Warwick, CV34 4AB, UK, 9British Heart 
Foundation, 4 Fitzhardinge Street, London, W1H 6DH, UK, 10Allergy & Respiratory Research Group, Centre for Population Health Sciences, The 
University of Edinburgh, Levinson House, 20 West Richmond Street, Edinburgh, EH8 9DX, UK and  11CAPHRI, University of Maastricht, the 
Netherlands
Email: Rachna A Begh - r.begh@bham.ac.uk; Paul Aveyard - p.n.aveyard@bham.ac.uk; Penney Upton - p.upton@worc.ac.uk; 
Raj S Bhopal - raj.bhopal@ed.ac.uk; Martin White - martin.white@newcastle.ac.uk; Amanda Amos - amanda.amos@ed.ac.uk; 
Robin J Prescott - robin.prescott@ed.ac.uk; Raman Bedi - raman.bedi@kcl.ac.uk; Pelham Barton - p.m.barton@bham.ac.uk; 
Monica Fletcher - m.fletcher@educationforhealth.org.uk; Paramjit Gill - p.s.gill@bham.ac.uk; Qaim Zaidi - zaidiq@bhf.org.uk; 
Aziz Sheikh* - aziz.sheikh@ed.ac.uk
* Corresponding author    
Abstract
Background: The prevalence of smoking is higher among Pakistani and Bangladeshi males than
among the general population. Smokers who receive behavioural support and medication
quadruple their chances of stopping smoking, but evidence suggests that these populations do not
use National Health Service run stop smoking clinics as frequently as would be expected given their
high prevalence of smoking. This study aims to tackle some of the main barriers to use of stop
smoking services and adherence to treatment programmes by redesigning service delivery to be
more acceptable to these adult male populations. The study compares the effectiveness of trained
Pakistani and Bangladeshi smoking cessation workers operating in an outreach capacity ('clinic +
outreach') with standard care ('clinic only') to improve access to and success of National Health
Service smoking cessation services.
Methods/design: This is a pilot cluster randomised controlled trial based in Birmingham, UK.
Super output areas of Birmingham will be identified in which more than 10% of the population are
of Pakistani and/or Bangladeshi origin. From these areas, 'natural geographical communities' will be
identified. Sixteen aggregated agglomerations of super output areas will be identified, separating
areas from each other using buffer regions in order to reduce potential contamination. These
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natural communities will be randomised to 'clinic + outreach' (intervention) or 'clinic only' (control)
arms. The use of stop smoking services and the numbers of people quitting smoking (defined as
prolonged self-reported abstinence at four weeks, three months and six months) will be assessed
in each area. In addition, we will assess the impact of the intervention on adherence to smoking
cessation treatments and patient satisfaction.
Trial registration: Current Controlled Trials ISRCTN 82127540.
Background
The problem being addressed
The UK has a national network of National Health Service
(NHS) smoking cessation services offering a range of
interventions proven to be effective in facilitating smok-
ing cessation. Those using these cessation services are four
times more likely to succeed in quitting than those who
attempt to stop smoking on their own[1]. Bangladeshi
and Pakistani males, who have a high prevalence of smok-
ing[2] are however half as likely as the White population
to use these services[3,4]. This may be because Bangla-
deshi and Pakistani smokers are poorly served by current
smoking cessation services. One possibility is that existing
service formulations need to be adapted to better meet the
needs of these minority populations.
This study aims to provide key components of the evi-
dence base for promoting effective smoking cessation in
these two large minority ethnic communities comprising
over one million UK citizens (1.8% of the UK popula-
tion)[5]. Bangladeshis and Pakistanis are two of the most
socio-economically deprived and marginalised communi-
ties in the UK with persistent poor health outcomes for a
range of long-term disorders. Stopping smoking is espe-
cially important in these populations as Pakistani and
Bangladeshi groups are at significantly increased risk of
heart disease, stroke and type 2 diabetes when compared
to the White population[6,7]; stopping smoking would
reduce the risk of these conditions by at least one-
third[8,9].
We have been pursuing a phased programme of
work[3,10,11], in line with the Medical Research Coun-
cil's (MRC) complex intervention framework, studying
smoking behaviour in these communities which we seek
to advance to a definitive (Phase III) trial stage [12-14].
The work reported here seeks to refine and pilot a theoret-
ically informed, culturally acceptable, trained community
smoking cessation worker model of care suitable for sub-
sequent formal evaluation in a multi-centre cluster ran-
domised controlled trial[12].
We are focusing on these two ethnic groups because of the
high prevalence of smoking, the shared religious tradi-
tion[15], the high disease burden from cardiovascular,
cerebrovascular and respiratory disorders[16], and our
collective expertise in researching these communities. It is
anticipated that the insights gleaned from in-depth work
with these populations will provide important transfera-
ble lessons for future smoking cessation work in other
minority ethnic groups.
Smoking prevalence in ethnic minority communities
Data from the 2004 Health Survey for England revealed
marked ethnic and gender variations in smoking patterns,
with cigarette smoking prevalence being particularly high
amongst Bangladeshi men (40%, compared with the
national average of 24%)[2]. Smoking prevalence in Paki-
stani males (29%) was somewhat higher than the
national average. This was in stark contrast to smoking fig-
ures in Pakistani (5%) and Bangladeshi (2%) women,
which were significantly lower than the national average
for women (23%). Similarly, smoking prevalence in
males was particularly high in Bangladesh and Paki-
stan[17].
The English national smoking cessation services collect
data quarterly on ethnicity using very broad ethnic group-
ings. Although 2.3% of English smokers are 'Asian'[4],
only 1% of clinic users were classified as being 'Asian'[18],
raising uncertainty over whether the national network of
services is able to attract and meet the needs of these pop-
ulations. Parts of Birmingham (and some other cities in
the UK) have begun to develop models of care similar to
those that are proposed in this study; these are however
being implemented on a somewhat ad hoc basis, without
clear evidence of effectiveness, and without rigorous eval-
uation.
Systematic reviews and meta-analyses have found that
behavioural (counselling)[19] and some pharmacological
interventions [20-22] increase the likelihood of successful
smoking cessation and these findings have been incorpo-
rated into evidence-based guidelines for smoking cessa-
tion [23-25].
Although increasing smoking cessation remains a
national priority[26], these effective interventions are
underused within ethnic minority communities[3]. There
is thus at present little evidence on how effectively to facil-
itate smoking cessation in Bangladeshi and Pakistani
communities. There has, perhaps as a consequence, beenTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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few attempts to specifically target or tailor smoking cessa-
tion services to meet the needs of these communi-
ties[27,28]. This is of concern as qualitative work (using
in-depth interviews and focus groups), has shown that
culture and religion are strong influences on smoking atti-
tudes and behaviours[3]. There was found to be wide-
spread awareness of the dangers of smoking and a high
degree of motivation to quit, with many quit attempts;
these however tended to rely on "willpower" alone and
were (unsurprisingly) typically unsuccessful. Knowledge
of, beliefs about and limited access to known effective
smoking cessation interventions were shown to be impor-
tant cultural and structural barriers to improving quit
rates. The authors proposed that services should be flexi-
ble, multi-lingual, supportive and involve local people in
their delivery.
Although many smokers also emphasised the importance
of religious centre based services, a telephone survey of a
random sample of 50 British mosques found that whilst
most would like to support smokers to quit, few Imams
(religious leaders) believe that their centres currently have
the capacity to support this work making a mosque-based
intervention unfeasible at present. Similarly, our enquir-
ies have found that the prospects of a Fatwa (religious
edict) – something which qualitative work also suggested
might be useful to help smokers quit – is also very
unlikely in the near future in Britain (Mogra I, Chair of
Mosque and Community Affairs Committee, Muslim
Council of Britain, personal communication, 2005) and
even in countries where such Fatwas have been issued the
impact of these has, at best, been extremely limited[29].
Rationale for this trial
Our enquiries, the qualitative work already undertaken,
and the experiences of services that have begun to develop
new styles of smoking cessation service delivery suggest
that "grass-roots" trained community smoking cessation
worker delivered interventions are likely to prove feasible,
accessible and effective.
This study seeks to build on these insights and develop
and then pilot a model of community stop smoking serv-
ices that will be "owned by" and prove acceptable to Bang-
ladeshi and Pakistani male smokers, and their wider
communities. Our enquiries indicate that there are several
models of care centred on bi- or multi-lingual trained
community smoking cessation workers currently in exist-
ence. These range, for example, from facilitators focusing
on improving access to existing mainstream smoking ces-
sation services to developing home-based specialist paral-
lel services. It is, however, important to prioritise the
evaluation of interventions that are potentially generalis-
able across the NHS hence the focus here is on interven-
tions that have the potential to integrate with existing
smoking cessation services.
Aims and study questions
Aim
To develop and investigate the potential of a culturally
appropriate community smoking cessation service in
improving access to and the effectiveness of smoking ces-
sation services for male adult Pakistani and Bangladeshi
smokers.
Study questions
Primary study questions:
1. What are the rates at which the population of Paki-
stani and Bangladeshi male smokers will set a quit
date with the stop smoking services in the intervention
and control areas?
2. What proportions of those setting a quit date in the
intervention and control areas achieve biochemically
verified prolonged abstinence from smoking at a) 4
weeks, b) 3 months and c) 6 months after the agreed
quit date?
3. What is the likely degree of contamination of the
intervention and control areas and the design effects
that need to be taken into consideration when con-
ducting sample size calculations for a definitive cluster
randomised controlled trial?
4. What are the key components of the intervention as
it develops and how do these components relate to the
outcome measured by the rates of setting quit dates
and abstinence among those setting quit dates?
Secondary study questions:
5. What proportion of Pakistani and Bangladeshi male
smokers that book an appointment with the stop
smoking service attend the initial appointment and set
a quit date in the intervention and control areas?
6. What smoking cessation treatments do Pakistani
and Bangladeshi men use in the intervention areas,
facilitated by outreach workers, and in the control
areas, without such workers?
7. What are the experiences of the services of the rele-
vant groups in each of the trial arms and how satisfied
are they?
8. What proportions of those enrolled adhere to the
interventions chosen?Trials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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9. What impact, if any, are these interventions likely to
have on smokeless (oral) tobacco use in these smok-
ers?
10. What are the costs, from a health service perspec-
tive, of delivering these interventions?
Methods
Study/design
This is a pilot cluster randomised controlled trial being
undertaken in Birmingham East and North Primary Care
Trust (BEN PCT) and the Heart of Birmingham Teaching
Primary Care Trust (HoB tPCT). The trial compares the
change in the key outcome variables between intervention
and control areas. The change is the difference between
the intervention period rates of activity in the intervention
area and the same period one year prior to the interven-
tion. An analogous figure is calculated for the control
areas and the difference in these changes are then com-
pared.
Interventions
The interventions being tested in this two arm pilot trial
are: (i) standard stop smoking advisor based in smoking
cessation clinic ('clinic only' control) vs. (ii) community
based stop smoking advisor working in an outreach
capacity, to support existing clinics enhance the tailoring
of smoking cessation treatments to the specific needs of
Pakistani and Bangladeshi male smokers and/or to pro-
vide smoking cessation treatment themselves in a location
of their choosing ('clinic + outreach').
The aim of both models of care is to attract clients, to con-
vince them of the value of behavioural support and phar-
macotherapy, to provide these interventions themselves
or point people towards clinics providing such treatment,
and to persuade clients to persist with treatment until the
risk of relapse is substantially decreased.
'Clinic only' (control)
In the areas allocated to the 'clinic only' arm, the NHS
stop smoking services will attract clients in the normal
way. The model is well developed in BEN PCT and HoB
tPCT. The model consists of health care service providers,
including general practitioners (GPs), nurses, pharmacists
and stop smoking advisors (SSAs) who are trained in
smoking cessation, and work to standards set and moni-
tored by the local stop smoking services.
'Clinic + outreach' (intervention)
In areas allocated to the 'clinic + outreach' arm, the NHS
stop smoking services will attract clients with additional
support from four community based stop smoking advi-
sors, also known as 'outreach workers'. These outreach
workers come from the ethnic groups of interest (i.e. two
of Bangladeshi origin and two of Pakistani origin) and
live in the communities that they serve. Between them,
they speak several relevant languages (i.e. Sylheti, Bengali,
Punjabi, Mirpuri, Urdu and English).
A specialised training programme for the outreach work-
ers will be organised prior to the start of the intervention,
to combine training in smoking cessation with a special
understanding of the norms and beliefs about tobacco in
the Pakistani and Bangladeshi communities. This will
consist of:
 Standard two-day SSA training delivered by HoB
tPCT
 Three-day health promotion training course deliv-
ered by HoB tPCT on exploring ways to promote well-
being and health, and techniques involved in the
planning, preparation and delivery of approaches.
 Sessions given by primary care staff at the University
of Birmingham on research skills, communication
skills, the function of the NHS, the cultural context of
the work, and discussion of the outreach role.
We envisage that the outreach workers will take the fol-
lowing approaches to improve the reach of and access to
the smoking cessation services:
 Undertake community engagement work to help
increase awareness of smoking cessation services
 Assist existing service providers with the delivery of
stop smoking support and promotions
 Provide stop smoking support and medication for
people in non-clinic venues, e.g. workplaces, public
buildings.
Additionally, we envisage that the outreach workers will
draw on their in-depth understanding of beliefs about and
attitudes towards smoking, in order to:
 Raise awareness of the dangers associated with smok-
ing and counsel smokers wishing to quit
 Identify suitable quit dates (which may be based on
key religious events such as a Friday congregational
prayer, journey on Umrah or Hajj (pilgrimage to
Mecca), or to coincide with the month of Ramadan,
for example)
 Highlight religious objections to smoking, where
appropriateTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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 Make available existing and custom-made literature,
telephone (Asian QuitLine) and other support materi-
als.
We hypothesise that the 'clinic + outreach' model will
attract more patients to the service because it is seen as
more culturally appropriate. In addition, the service
should influence the proportion of people successfully
attempting to stop smoking by encouraging patients to
persist with treatment.
Randomisation
We will use census super output areas (SOAs) as the unit
of allocation[30]. In order to define these communities,
initially all those SOAs within the study area with a com-
bined Bangladeshi and Pakistani population of more than
10% will be identified and then mapped at ward level,
enabling the street boundaries of each SOA to be seen.
Contiguous SOAs will then be aggregated into natural
communities (i.e. areas where people live, work, shop etc)
using the local knowledge of the LSSS managers and advi-
sors. SOAs in which more than 30% of the population are
Pakistani and Bangladeshi will be considered to be high-
density areas, while SOAs with 10–29% of the population
being from these groups will be defined as low-density
areas.
A total of 16 aggregated areas, sufficiently geographically
dispersed, will be created to be randomised; there will
thus be eight SOAs in each arm. For the randomisation,
we will stratify, firstly by the proportion of Pakistani and
Bangladeshi residents and secondly by absolute popula-
tion size, to create eight areas that include high target pop-
ulation density and eight that are low-density areas. The
high density areas will be further subdivided into those
areas with target populations of Bangladeshi and Paki-
stani men above and below 10,000. The low density areas
will be further subdivided into those areas with target
populations above and below 300. Table 1 shows how the
areas will be allocated. Randomisation will be undertaken
by the study statistician who has no knowledge of the geo-
graphical areas using permuted blocks. Within each of the
four strata, two areas will be randomly allocated to 'con-
trol' and two to 'intervention' arms. Maps of the final
areas and their allocation to the two study arms are shown
in Figures 1 and 2.
In studies in which the number of units randomised is rel-
atively small, stratified randomisation of communities
should ensure equal distribution of key potential con-
founders. However, potential confounders are also
important contextual factors affecting the success or oth-
erwise of the interventions and thus possible effect-modi-
fiers. We will therefore gather data on relevant aspects of
the communities (in particular socio-economic position,
since this is a strong predictor of smoking status) partici-
pating in the trial. Such data will be critical in enabling
generalisation of the lessons learnt from this pilot trial.
Protecting against sources of bias and reducing 
contamination
The main source of bias in this trial is likely to arise from
contamination (i.e. people helped to stop smoking with
the aid of the LSSS who live in 'clinic only' areas). The
potential for contamination will be reduced by careful
planning. First, natural communities will be chosen –
places where local intelligence tells us people tend to live
and work. Second, buffer zones will be created around the
trial areas that are neither 'clinic only' or 'clinic + outreach'
in order to reduce the possibility of people living in con-
trol areas crossing into intervention areas and coming
across intervention workers (see Figures 1 and 2). This will
mean excluding large areas that have both high and low
densities of Pakistani and Bangladeshis living in them that
would otherwise have participated in the trial. We will be
able to gauge the degree of contamination by using a
before-after design. Working with anonymised versions of
the LSSS databases, we will analyse data on the use of serv-
ices by Pakistani and Bangladeshi residents of interven-
tion and control areas and other areas of Birmingham
mostly distant from our intervention and control areas.
We will thus be able to contrast the change in service use,
not simply differences in service use. Contamination
would be marked by increases in service use in areas
assigned to either the control or special intervention that
would not be seen in outside areas that served as the exter-
nal control. Informal conversations with patients, service
providers, and outreach workers will also be carried out to
provide additional insight into the extent of any contam-
ination.
The two quantitative primary outcomes are uptake and
abstinence rates. Nearly all people contributing data to
these rates will be unaware of the trial. Thus the potential
for information bias is minimal.
The first three primary study questions will be answered
using LSSS data, most of which are collected routinely
(LSSS Dataset). The fourth primary question will be
answered by a qualitative study, consisting of longitudinal
focus group discussions with the outreach workers, obser-
vation of their management meetings, analysis of their
diaries, and some shadowing of their activities.
The secondary questions will be addressed either through
LSSS data on treatments used, or through an Extended
Dataset collected from a self-selected sub-sample of par-
ticipants in the trial (Extended Dataset). Data sources and
outcome measures for each of these research questions areTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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Map of randomisation areas in HoB tPCT Figure 1
Map of randomisation areas in HoB tPCT.
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Map of randomisation areas in BEN PCT Figure 2
Map of randomisation areas in BEN PCT.
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summarised in Table 2. The flow of participants through
the trial is shown in Figure 3.
Local Stop Smoking Service (LSSS) Dataset
Inclusion criteria
Any male (18 years) Pakistani or Bangladeshi using the
NHS stop smoking services in the study areas will be eligi-
ble for inclusion in this study.
The LSSS routinely records abstinence rates at four weeks
post quit date. Anyone from the target population who
maintains abstinence at four weeks will be eligible for fol-
low-up at three months. Service users will be contacted by
the Birmingham 'Call 2 Quit' line – a special project to
enhance the stop smoking services in Birmingham – and
invited to attend a clinic appointment for verification of
abstinence using expired carbon monoxide. Any service
users who are still abstinent at three months will be fol-
lowed up in the same way at six months.
Exclusion criteria
Any users of the NHS stop smoking services who are not
from the relevant ethnic groups will be excluded. Anyone
from the target population who does not maintain absti-
nence at four weeks will not be eligible for follow-up at
three or six months.
Consent
Consent from patients will not be required as the data will
be received from the Primary Care Trusts (PCTs) in an
anonymised form.
Losses to follow-up
Loss to follow-up is not an issue in relation to the primary
outcomes of use of services or abstinence. People who
attend a stop smoking service set a quit date at one point
in time or they do not, and only those who do are moni-
tored by the LSSS. Furthermore, the other important out-
comes (i.e. cessation at four weeks, and three and six
months) are routinely monitored by the service too. As is
standard protocol of smoking cessation research, people
who are lost to follow-up are deemed to be smoking
again[31,32].
Extended Dataset
The aim of the Extended Dataset is to provide more
detailed data on attendance and adherence than can be
obtained from the NHS records and to provide informa-
tion on service use satisfaction that cannot be obtained
from NHS records. To accomplish this, Pakistani and
Bangladeshi men using particular NHS services will be
approached and asked for consent to provide this infor-
mation to the research team.
Recruitment
A sub-sample of individuals who go through the NHS
LSSS in these areas will be invited into a study of their per-
ceptions of the service. We will recruit providers of NHS
stop smoking services in both our study areas to collect
this additional data. These will be drawn from those stop
smoking advisors, nurses and pharmacists who provide
smoking cessation services in or near the study areas that
have, on past data, delivered stop smoking services for
Pakistani and Bangladeshi men residing in the interven-
tion or control areas. We will supply each SSA taking part
Table 1: Randomisation allocation
Number of areas Bangladeshi and Pakistani population density Bangladeshi and Pakistani population size Study arm
2 High* <10,000 Clinic only
2 High <10,000 Clinic + outreach
2 High >10,000 Clinic only
2 High >10,000 Clinic + outreach
2 Low** <300 Clinic only
2 Low <300 Clinic + outreach
2 Low >300 Clinic only
2 Low >300 Clinic + outreach
*Pakistani and Bangladeshi populations = >30%
** Pakistani and Bangladeshi populations = 10–29%Trials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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Flow diagram of clusters and participants in the trial Figure 3
Flow diagram of clusters and participants in the trial.
in the extended data collection with a pack containing a
brief procedure guide, information sheets, consent forms,
data collection forms and a method to contact the study
team. The baseline patient questionnaire incorporates
items from a culturally valid tobacco use question-
naire[33]. Service users will be asked to participate by
their service provider (outreach worker, nurse, specialist
SSA or pharmacist) during routine consultation. These
data will be supplied to the study team confidentially, but
not anonymously.
Inclusion criteria
All consenting, self-assigned (using Census 2001 catego-
ries)[5] Pakistani and Bangladeshi male adult (18 years)
regular smokers (defined as self-declared usage of on aver-
age 1 cigarette/day) using the NHS stop smoking services
will be eligible to participate.
Exclusion criteria
Any users of the NHS stop smoking services who are not
from the relevant ethnic groups will be excluded.Trials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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Table 2: Research questions and associated trial outcome measures
Research question Outcome measure Data source
LSSS Dataset
1. What is the rate at which the population of 
Pakistani and Bangladeshi male smokers will set 
a quit day with the stop smoking services in the 
intervention and control areas.
Recruitment rate is defined as the number of 
relevant population setting a quit day with the 
services as a fraction of all those estimated to 
have attempted to stop.
LSSS routine database
2. What proportions of those setting a quit day 
in the intervention and control areas achieve 
prolonged abstinence from smoking at a) 4 
weeks, b) 3 months and c) 6 months after the 
agreed quit day?
a) Number of quits 
(measured by self assessment questionnaire & 
CO monitoring)
Total number of smokers* accessing LSSS
b) & c) number of quits 
(measured by self assessment questionnaire & 
CO monitoring)
a) LSSS routine database
b) & c) LSSS data collected specifically for the 
trial
3. What is the likely degree of contamination of 
the intervention and control areas and the 
design effect that need to be considered when 
conducting sample size calculations for a 
definitive cluster randomised controlled trial?
The design effect from cluster randomisation 
will be calculated from the multilevel analysis. 
Contamination cannot be easily measured; 
however, we have external controls which will 
help indicate whether it is occurring.
4. What are the key components of the 
intervention as it develops and how do these 
components relate to the outcome measured 
by the rates of setting quit dates and abstinence 
among those setting quit dates?
Qualitative data Focus groups with outreach workers
Observation of management meetings
Shadowing
Analysis of outreach worker diaries
End of project interviews with outreach 
workers
5. What proportion of Pakistani and 
Bangladeshi male smokers that book an 
appointment with the stop smoking service 
attend the initial appointment and set a quit day 
in the intervention and control areas?
To be estimated from a sample of service 
providers records
SSA records
LSSS Routine database
Extended Dataset
6. What smoking cessation treatments do 
Pakistani and Bangladeshi men use in the 
intervention areas, facilitated by outreach 
workers, and in the control areas, without such 
workers?
Numbers of clients choosing each available 
treatment option (e.g. NRT, Zyban etc)
LSSS Routine database Patient satisfaction 
questionnaire administered by LSSS 'Call to 
Quit' team
7. What are the experiences of the services of 
the relevant groups in each of the trial arms 
and how satisfied are they?
Patient satisfaction Patient satisfaction questionnaire administered 
by LSSS 'Call 2 Quit' team
8. What proportions of those enrolled adhere 
to the interventions chosen?
Numbers using oral tobacco during quit 
attempt (self report)
Number of people adhering to each medication 
used in each arm of the trial (self report)
Attendance at clinic in each arm of the trial
Adherence rating week by week then averaged, 
collected by SSA on extended data monitoring 
form
9. What impact, if any, are these interventions 
likely to have on smokeless (oral) tobacco use 
in these smokers?
Numbers using oral tobacco during quit 
attempt (self report)
Frequency rating week by week, collected by 
SSA on extended data monitoring form
Frequency of use of oral tobacco during this 
quit attempt rating on Patient satisfaction 
questionnaire administered by LSSS 'Call to 
Quit' team
10. What are the costs, from a health service 
perspective, of delivering these interventions?
Estimated benefits of the intervention in terms 
of QALYs or LYGs.
Additional costs to NHS of
(i) Employment, training, management of 
outreach workers-
(ii) Extra resources used by LSSS – e.g. 
medication, behavioural support
(Calculated from estimates of extra time used)Trials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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Consent
Written consent will be obtained from all users prior to
their inclusion in this extended data collection phase.
Losses to follow-up
Those individuals recruited in the Extended Dataset will
be asked about their satisfaction with the stop smoking
service they received. It is the experience of LSSS that indi-
viduals who return to smoking do not return to clinic,
while those who have succeeded do so and are typically
very pleased with the care they received. Thus, loss to fol-
low-up is a potentially major bias in assessing these out-
comes. However, these individuals will have consented to
follow up and thus we seek to minimise loss of informa-
tion from those who do not stop smoking by telephone
contact from the Birmingham Call 2 Quit line.
Embedded qualitative work
A key aim of phase II of the MRC Complex Intervention
Framework is to develop and test out interventions. We
will conduct longitudinal qualitative work to help define
the fundamental components of the intervention and to
develop a step-by-step account of how the intervention
evolves over time. The project researcher will attend
monthly working meetings between the outreach workers
and the management team to record discussions about
activities undertaken, the response of the population to
them, and changes made to work plans as they emerge.
Furthermore, the outreach workers will be encouraged to
keep detailed weekly records of what they do, which will
form part of their regular progress reports to their supervi-
sors at the stop smoking services. The project researcher
will also shadow the outreach workers, making field notes
while they engage in outreach activity on the streets and
during promotional events and clinic sessions. Focus
group discussions with the outreach workers will be car-
ried out at quarterly intervals during data collection in
order to:
 Define more clearly the role of the outreach worker
in assisting Bangladeshi and Pakistani smokers to stop
smoking
 Explore the approaches taken when recruiting service
users and supporting smoking cessation and why they
chose those particular approaches
 Understand how the service provided changes over
time, as their role, and what does and does not work,
becomes clearer.
One-to-one interviews with individual outreach workers
will be carried out at the end of the study to capture any
differences in ways of working.
We also aim to capture what happens in the pre-existing
clinic based intervention (pharmacies), in order to be able
to record how different the 'clinic + (outreach)' interven-
tion is in terms of approaches to cessation support. Whilst
it is often expected that there is a standard approach, in
practice there is often surprisingly large variation. To this
end we will carry out a small number of brief one-to-one
interviews with a purposive sample of pharmacists in the
study area to develop a clearer picture of any added value
of the outreach worker intervention.
Risks to the safety of service users in the trial
There are no anticipated risks to clients from participation
in this study over and above those associated with using a
smoking cessation service. Most participants will not even
know that they are participating, as their routinely col-
lected NHS data will be passed in anonymised form to the
researchers. For patients participating in the Extended
Dataset, there is the risk of inadvertent disclosure that they
smoke to relatives that do not know this; however the
study team are aware of this and will minimise this risk.
Outcome measures and analysis
Proportion of people attending but not setting quit dates
Stop smoking services return only the number of people
setting quit dates with the service, so these data are not
routinely collected. To obtain these, we need to identify
service providers in intervention and control areas that
keep meticulous booking records. If we find such provid-
ers during the collection of the Extended Dataset, we will
try to estimate the proportion of people who attend with-
out setting a quit date. However, it is unlikely that book-
ing records give the ethnic group of the person booking,
so this may prove impossible. Should appropriate data be
available, the number of quit days set in relation to the
number of bookings will be examined using a Poisson
multilevel model for intervention and control areas.
Denominator for the proportion of smokers setting quit dates
Our overall aim is to develop and refine the intervention,
to pilot it, and have the data needed to inform sample size
calculations for a definitive trial evaluating these interven-
tions. In order to perform sample size calculations for a
future trial, we aim to assess the reach of the interventions
in attracting smokers wanting to quit. For the purposes of
this study, reach has been defined as the proportion of
each relevant ethnic group setting a quit date using the
stop smoking service, with the denominator for this being
all those of relevant ethnic group attempting to quit dur-
ing the same period. We are estimating this latter number
as it cannot be directly measured. We have searched a vari-
ety of sources to give information on the proportion of
each ethnic group that attempted to quit in the past year
and these data are not available. No local survey can truly
randomly survey Pakistani and Bangladeshi populationsTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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because there is no publicly available local sampling
frame that records ethnicity. Consequently, we will use
the Smoking Toolkit Study to provide relevant data on the
proportion of people that attempted to quit in the past
year for the general population and assume that this figure
is approximately the same in Pakistani or Bangladeshi
men[34].
Stop smoking services routinely record information about
each of their patients, including their age, gender, ethnic
group, type of service used, medication used and out-
come. This will be used to give both a before and after
measure of the use of the service by the relevant groups
(i.e. males of Pakistani and Bangladeshi ethnic group).
Thus, we will have, for each area, the rate of use of the
service for 12 months prior to the intervention that will
serve as a baseline variable in the analysis (see Table 3).
The after measure will be the same data collected for the
12 months during which the outreach workers are active.
These data will be supplied anonymously from BEN and
HoBt PCTs and this does not rely on data collection devel-
oped for the study. As noted above, the before-after design
will allow control for intrinsic variability between areas.
As such there will be no attempt to assess baseline balance
between the intervention and control areas.
Although we will estimate the proportion of people set-
ting a quit date, we cannot truly know the denominator,
as in many cases people set multiple quit dates, hence we
will consider this a rate and the 'denominator' an offset in
the analysis.
Table 3: Use of LSSS by randomisation area residents for the baseline period (1st November 2006 – 31st October 2007)
Area number Number of 
Pharmacies
Numbers using 
any LSSS 
service 06/07
Number of 
smokers using 
LSSS within area 
they live
Number of 
smokers using 
LSSS in other 
areas of 
randomisation
Number of 
smokers* using 
LSSS users out of 
study zone
Number of 
smokers using 
unidentified 
LSSS
10 7 0 0 7 0
21 1 0 1 0 9 0
3 0 29 0 8 20 1
43 7 9 4 1 4 3 2 2
551 5 5 5 7 2 7 7 1 9
641 3 6 4 3 5 8 4 4
76 9 8 5 5 0 4 2 1
82 6 0 1 5 0
91 2 0 0 2 0
10 0 4 0 0 3 1
11 0 8 0 5 3 0
12 0 3 0 0 3 0
13 0 11 0 8 2 1
14 1 8 0 3 5 0
15 0 2 0 0 2 0
16 0 5 0 0 5 0
*Bangladeshi or Pakistani Males aged 18 years or overTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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Quantitative analysis will use a multilevel approach. In
this model the outcome variable will be the number of
individuals setting a quit date in each of the 16 ran-
domised areas. The quasi-denominator is the estimated
number wishing to quit in each area, and the log of this
number will be used as an offset in a Poisson regression
model. Independent variables in the model will be the
group (control or intervention) and the log of the num-
bers setting a quit date in the previous 12 months before
the trial. The randomised areas will be included in the
model as a random effect, thereby allowing for the cluster-
ing inherent in the design[35]. This will be used in esti-
mating the intra-class correlation coefficient, which in
turn will determine the design effect. This is the multiplier
which has to be applied to standard sample size formulae
to allow for the effect of randomising at the cluster level
instead of the individual level[36]. The stratification used
in producing the randomisation will not be utilised in the
analysis.
Definition and modelling of abstinence rates
The quit rate is defined as the proportion of people
achieving abstinence, with a denominator of all those
who attended the service and set a quit date. Quitting is
defined as prolonged abstinence, which is defined as
allowing lapses during the first two weeks of the quit proc-
ess measured according to the Russell standard[37]. Self-
reporting is substantiated by biochemical validation using
expired carbon monoxide (less than 10 parts per mil-
lion)[38].
The modelling will follow the same approach as described
above for calculation of usage rates, except that we will
have a true denominator. We will therefore use multilevel
logistic regression models rather than Poisson models.
Smoking cessation treatments chosen
The proportion of LSSS clients choosing each available
treatment option will be calculated from the information
provided in the routine stop smoking service.
Patient experiences
We have developed a patient satisfaction questionnaire,
which will be used to collect information on the experi-
ences of service users. This will be examined for the inter-
vention group using appropriate multilevel models.
Estimating adherence
The standard forms for recording the clinical contact with
patients record whether the person is using nicotine
replacement therapy (NRT) or not, but not degree of
adherence, which is quite complicated and impractical for
NHS to measure accurately. We will therefore use a meas-
ure that defines good or less than good adherence, which
is defined for each type of treatment. Stop smoking advi-
sors will be asked to record adherence weekly on a modi-
fied routine monitoring form.
This will be modelled with random effects logistic regres-
sion, with the numerator being the number of people who
adhere well to treatment in each week and the denomina-
tor being all those receiving treatment. Repeated measures
on the same individuals are correlated within individuals
and will be accounted for in the analyses.
Estimation of costs
We will approach this using the models developed for
other purposes (e.g. the National Institute for Health and
Clinical Excellence (NICE) reports on NRT[39]). Thus, if
long-term abstinence can be estimated, we should be able
to use this to derive an estimate of the benefits of the inter-
vention in terms of Quality Adjusted Life Years (QALYs)
or Life Years Gained (LYGs). We will therefore estimate
the additional costs of:
 The employment, training, and management of the
outreach workers
 The extra resources used, including extra medication,
extra behavioural support given by other providers as
a result of additional activity generated by the out-
reach workers. We will calculate this from the eco-
nomic costs to the NHS estimated from time used
and/or observations of extra time taken.
Qualitative work
A modified Framework approach will be used systemati-
cally to make sense of the different types of qualitative
data that will be generated[40]. Issues that emerge from
these data will be indexed and collated to form broad cat-
egories. The categories will be examined and emergent
themes identified in regular discussions of the multi-dis-
ciplinary qualitative sub-group, with emerging ideas
being incorporated into future rounds of the qualitative
data collection.
Current study status
The intervention period began on 1st November 2007 and
ran for 12 months, with an end date of 31st October 2008.
Final data collection and analysis of data in relation to the
primary outcomes is currently underway and we antici-
pate will be completed by July 2009.
Protocol amendments
From the time of writing this protocol, the following
changes have been made.
We aimed to measure the rate at which Pakistani and
Bangladeshi male smokers set a quit date with the stop
smoking services in the intervention and control areas. WeTrials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
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defined reach as the proportion of each relevant ethnic
group setting a quit date using the stop smoking service,
with the denominator for this being all those of relevant
ethnic group attempting to quit during the same period.
As this latter number could only be estimated, we investi-
gated whether The Health Survey for England ethnic
boosted sample data had the relevant information (i.e.
the proportion that tried to stop in the previous year).
These data did not, however, contain this information
and we have therefore assumed that the proportion of
Pakistani and Bangladeshi males that attempt to quit is
the same as the proportion of all other ethnic groups. This
assumes that what is true of the majority population is
true of Pakistani and Bangladeshi populations.
Prior to the start of the study, the randomisation of the
intervention and control areas were switched, as the initial
allocation meant more Pakistani and Bangladeshi target
populations resided in areas allocated to the control than
intervention. The managers of HoB and BEN PCTs pre-
ferred that the outreach workers were given the opportu-
nity to reach more people, thus, the randomisation was
switched in consultation with the trial statistician and
Independent Project Steering Committee.
Initially, we aimed to follow-up LSSS service users who
achieved 4-weeks prolonged abstinence from smoking at
three months from the agreed quit date. The Birmingham
'Call 2 Quit' line was unable to do this at three months.
However six-month follow-up proceeded as planned.
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Abbreviations
BEN: Birmingham East and North Primary Care Trust;
HoBt: Heart of Birmingham Teaching Primary Care Trust;
LSSS: Local Stop Smoking Services; LYG: Life Years
Gained; NICE: National Institute for Health and Clinical
Excellence; NRT: Nicotine Replacement Therapy; PCTs:
Primary Care Trusts; PHIT: Public Health Information
Team; QALY: Quality Adjusted Life Years; RS3: Re-design-
ing Stop Smoking Services; SOA: Super Output Area; SSA:
Stop Smoking Advisor; SSS: Stop smoking Services.
Competing interests
Paul Aveyard has done consultancy work for Pfizer,
McNeil, and Xenva (now Celtic) Biotechnology with
regard to smoking cessation. All other authors declare that
they have no competing interests.
Authors' contributions
AS and RSB conceived this study and together led the bid
to secure funding for this work and manage the project.
AS, PU, and PA developed the trial protocol. PU, RAB, PA,
and AS managed the study. RSB, PG, MW, AA, RJP, RB,
PMB, QZ and MF all contributed to designing the study
and overseeing its implementation. PU and RAB were the
researchers employed on this project and led the drafting
of this paper. All authors commented on draft versions of
this manuscript and approved the final version prior to
submission.
Acknowledgements
This research was funded by the National Prevention Research Initiative 
http://www.npri.org.uk with support from the following organisations: Brit-
ish Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish 
Government Health Directorate; Department of Health; Diabetes UK; 
Economic and Social Research Council; Health & Social Care Research & 
Development Office for Northern Ireland; Medical Research Council; The 
Wellcome Trust; Welsh Assembly Government; and World Cancer 
Research Fund. Service support funding was provided by the Midlands Gen-
eral Practice Research Consortium (MidRec). PA is funded by the National 
Institute for Health Research.
We would like to acknowledge the following people for their help in the 
study: Nur Ahmed (Outreach Worker), Pauline Beale (acting Stop Smoking 
Manager for Birmingham East and North Primary Care Trust), Rishpal 
Chana (Specialist Stop Smoking Advisor), Ayaz Iqbal (Outreach Worker), 
Dale Ricketts (Stop Smoking Manager for Heart of Birmingham Teaching 
Primary Care Trust), Ros Salter (Central England Primary Care Research 
Network Manager), Farooq Shah (Outreach Worker) and Mohbur Ullah 
(Outreach Worker).
We would like to thank the members of our Independent Trial Steering 
Committee for their oversight and support: Tim Coleman, Marlie Ferenczi, 
Phil Hannaford (Chair) and Liam Smeeth.
References
1. Ferguson J, Bauld L, Chesterman J, Judge K: The English smoking
treatment services: one-year outcomes.  Addiction 2005,
100:59-69.
2. Sprotson K, Mindell J: Health survey for England 2004: Health
of Ethnic Minorities – Summary of Key Findings.   [http://
www.ic.nhs.uk/webfiles/publications/healthsurvey2004ethnicfull/
HealthSurveyforEngland210406_PDF.pdf].
3. Bush J, White M, Kai J, Rankin J, Bhopal R: Understanding influ-
ences on smoking in Bangladeshi and Pakistani adults: com-
munity based, qualitative study.  British Medical Journal 2003,
326:962-965.
4. Sproston K, Primatesta P: Risk factors for cardiovascular disease Volume
2. London: The Stationery Office; 2007. 
5. Census 2001   [http://www.statistics.gov.uk/cci/nugget.asp?id=273]
6. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R,
Sheikh A, et al.: Predicting cardiovascular risk in England and
Wales: prospective derivation and validation of QRISK2.  Brit-
ish Medical Journal 2008, 336:1475.
7. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P: Predict-
ing risk of type 2 diabetes in England and Wales: prospective
derivation and validation of QDScore.  BMJ 2009, 338:b880.
8. Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to
smoking: 50 years' observations on male British doctors.  BMJ
2004, 328:1519.
9. Critchley J, Capewell S: Smoking cessation for the secondary
prevention of coronary heart disease.  Cochrane Database of Sys-
tematic Reviews 2003:CD003041.
10. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KGMM, et
al.: Heterogeneity of coronary heart disease risk factors in
Indian, Pakistani, Bangladeshi, and European origin popula-
tions: cross sectional study.  British Medical Journal 1999, 319:215.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Trials 2009, 10:71 http://www.trialsjournal.com/content/10/1/71
Page 15 of 15
(page number not for citation purposes)
11. White M, Bush J, Kai J, Bhopal R, Rankin J: Quitting smoking and
experience of smoking cessation interventions among UK
Bangladeshi and Pakistani adults: the views of community
members and health professionals.  Journal of Epidemiology and
Community Health 2006, 60:405-411.
12. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P,
Spiegelhalter D, et al.: Framework for design and evaluation of
complex interventions to improve health.  BMJ 2000,
321:694-696.
13. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F,
et al.:  Designing and evaluating complex interventions to
improve health care.  British Medical Journal 2007, 334:455-459.
14. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M:
Developing and evaluating complex interventions: the new
Medical Research Council guidance.  BMJ 2008, 337:a1655.
15. Sheikh A, Gatrad A: Caring for Muslim patients Oxford: Radcliffe Med-
ical Press; 2000. 
16. Gill P, Kai J, Bhopal R, Wild S: Health care needs assessment:
Black and Minority Ethnic Groups.  In Health care needs assess-
ment. The epidemiologically based needs assessment reviews. Third Series
Edited by: Raftery J, Stevens A, Mant J. Abingdon: Radcliffe Medical
Press; 2007. 
17. The World Bank  2009 [http://go.worldbank.org/N2N84RDV00].
18. Statistics on NHS stop smoking services in England, April
2003 to March 2004  Department of Health Statistical Bulletin 2004
[http://www.dh.gov.uk/assetRoot/04/09/76/51/04097651.pdf].
19. Lancaster T, Stead LF: Individual behavioural counselling for
smoking cessation.  Cochrane Database of Systematic Reviews
2005:CD001292.
20. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking
cessation.  Cochrane Database of Systematic Reviews 2007:CD000031.
21. Silagy C, Lancaster T, Stead L, Mant D, Fowler G: Nicotine replace-
ment therapy for smoking cessation.  Cochrane Database of Sys-
tematic Reviews 2004:CD000146.
22. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ,
et al.:  The clinical effectiveness and cost-effectiveness of
bupropion and nicotine replacement therapy for smoking
cessation: a systematic review and economic evaluation.
Health Technol Assess 2002, 6:1-245.
23. Raw M, McNeill A, West RJ: Smoking cessation guidelines for
health care professionals.  Thorax 1998, 53(Suppl 5, Part
1):S1-S19.
24. ASH Scotland NHS: Smoking Cessation Guidelines for Scotland Edin-
burgh, ASH Scotland/NHS Health Scotland; 2004. 
25. West R, McNeill A, Raw M: Smoking cessation guidelines for
health professionals: an update.  Thorax 2000, 55:987-999.
26. Department of Health: Smoking kills. A White Paper on tobacco London,
The Stationery Office; 1998. 
27. Crossier A, McNeill A: Mapping black and minority ethnic
tobacco prevention resources.  2003 [http://www.dh.gov.uk/
assetRoot/04/08/08/85/04080885.pdf]. London, Department of
Health
28. Brown C: Tobacco and ethnicity: a literature review Edinburgh: ASH
Scotland; 2004. 
29. Radwan GN, Israel E, El-Setouhy M, bdel-Aziz F, Mikhail N, Mohamed
MK: Impact of religious rulings (Fatwa) on smoking.  Journal of
the Egyptian Society of Parasitology 2003, 33:1087-1101.
30. Census 2001   [http://www.statistics.gov.uk/Census2001/
product_ks_soas.asp]
31. West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smok-
ing cessation trials: proposal for a common standard.  Addic-
tion 2005, 100:299-303.
32. Foulds J, Stapleton J, Hayward M, Russell MA, Feyerabend C, Fleming
T, et al.: Transdermal nicotine patches with low-intensity sup-
port to aid smoking cessation in outpatients in a general hos-
pital. A placebo-controlled trial.  Arch Fam Med 1993, 2:417-423.
33. Hanna L, Hunt S, Bhopal RS: Cross-cultural adaptation of a
tobacco questionnaire for Punjabi, Cantonese, Urdu and Syl-
heti speakers: qualitative research for better clinical prac-
tice, cessation services and research.  Journal of Epidemiology and
Community Health 2006, 60:1034-1039.
34. West R: Key performance indicators: findings from the
Smoking Toolkit Study.  2008 [http://www.smokingineng
land.info].
35. Brown H, Prescott R: Applied Mixed Models in Medicine 2nd edition.
Chichester: John Wiley & Sons; 2006. 
36. Gulliford M, Ukoumunne O, Chinn S, Sterne J, Burney P, Donner A:
Methods for evaluating organisation- or area-based health
interventions.  In The Advanced Handbook of Methods in Evidence
Based Healthcare Edited by: Stevens A, Abrams K, Brazier J, Fitzpatrick
R, Lilford R. London: Sage; 2001:295-313. 
37. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan
GE: Measures of abstinence in clinical trials: issues and rec-
ommendations.  Nicotine Tob Res 2003, 5:13-25.
38. Department of Health: NHS Stop Smoking Services: service
and monitoring guidance, October 2007/08.  2007
[http:www.dh.gov.uk/
ePublicationsandstatisticPublicationPublicationsPolicyAndGuidancDH
_079644].
39. National Institute for Health and Clinical Excellence: Smoking ces-
sation – bupropion and nicotine replacement therapy.  2002
[http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11452].
40. Ritchie J, Spencer L: Qualitative data analysis for applied policy
research.  In Analysing Qualitative Data Edited by: Bryman A, Burgess
RG. London: Routledge; 1994:173-194. 